In a climate of disinformation, authoritarian resurgence, and geopolitical uncertainty, Europe needs journalists who ...

Story May 1 - Arvinas: After Arvinas announced during its Q1 results presentation that the biotech and partner Pfizer are dropping two phase 3 trials from their estrogen receptor degrader R&D plan ...